Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders.

Pharmaceutical

Rgenta Therapeutics

Simon Xi

Kathryn Gregory

Missy Fulton

Travis Wager

The Scientific Research team at Rgenta Therapeutics focuses on discovering and developing small-molecule medicines targeting RNA to treat oncology and neurological disorders. Comprising scientists, senior scientists, research associates, and scientific advisors, the team employs cutting-edge research methodologies to identify and validate novel therapeutic targets, optimize lead compounds, and advance promising candidates through preclinical development.

Scientific Research

About

Team members

Other teams at Rgenta Therapeutics

Director Team

Leadership Team